Literature DB >> 31168359

Hepatocellular Carcinoma Risk After Direct-Acting Antiviral Therapy.

Feng Su1, George N Ioannou1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31168359      PMCID： PMC6465785          DOI： 10.1002/cld.781

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  7 in total

1.  Liver Disease Outcomes after Sustained Virological Response in Patients with Chronic Hepatitis C Infection Treated with Generic Direct-Acting Antivirals.

Authors:  Ekram W Abd El-Wahab; Waleed M Abd Elgawad; Mohamed S Abdelaziz; Ashraf I Mikheal; Hanan Z Shatat
Journal:  Am J Trop Med Hyg       Date:  2022-02-28       Impact factor: 3.707

2.  Thalassemia and hepatocellular carcinoma: links and risks.

Authors:  Maria Marsella; Paolo Ricchi
Journal:  J Blood Med       Date:  2019-09-17

3.  Human Papillomavirus Infection Is Associated with Decreased Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients: Taiwan Nationwide Matched Cohort Study.

Authors:  Sung-Shuo Kao; Chia-Jung Li; James Cheng-Chung Wei; Cheng-Li Lin; Renin Chang; Yao-Min Hung
Journal:  Cancers (Basel)       Date:  2022-03-02       Impact factor: 6.639

4.  Immune-Related lncRNAs with WGCNA Identified the Function of SNHG10 in HBV-Related Hepatocellular Carcinoma.

Authors:  Jie Hou; Zhan Wang; Hong Li; Hongzhi Zhang; Lan Luo
Journal:  J Oncol       Date:  2022-07-06       Impact factor: 4.501

5.  Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature.

Authors:  Myung-Ho Kim; Mi-Young Kim; Shadi Salloum; Tongqi Qian; Lai Ping Wong; Min Xu; Yoojin Lee; Stuti G Shroff; Ruslan I Sadreyev; Kathleen E Corey; Thomas F Baumert; Yujin Hoshida; Raymond T Chung
Journal:  Hepatol Commun       Date:  2022-06-16

6.  Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial.

Authors:  Supachaya Sriphoosanaphan; Kessarin Thanapirom; Stephen J Kerr; Sirinporn Suksawatamnuay; Panarat Thaimai; Sukanya Sittisomwong; Kanokwan Sonsiri; Nunthiya Srisoonthorn; Nicha Teeratorn; Natthaporn Tanpowpong; Bundit Chaopathomkul; Sombat Treeprasertsuk; Yong Poovorawan; Piyawat Komolmit
Journal:  PeerJ       Date:  2021-02-09       Impact factor: 2.984

Review 7.  Multiple Roles for Hepatitis B and C Viruses and the Host in the Development of Hepatocellular Carcinoma.

Authors:  Kirk J Wangensteen; Kyong-Mi Chang
Journal:  Hepatology       Date:  2020-11-07       Impact factor: 17.425
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.